# Tenaya Therapeutics, Inc.: Form DEF 14A, filed Apr 16, 2026

- Company: [Tenaya Therapeutics, Inc.](/companies/tnya.md) (CIK 1858848)
- Form: DEF 14A
- Filed: 2026-04-16
- Accepted by EDGAR: Apr 16, 2026, 09:00 ET
- Period: 2026-05-27
- Accession: 0001193125-26-158079
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1858848/000119312526158079/tnya-20260415.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1858848/000119312526158079/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1858848/000119312526158079/tnya-20260415.htm

Filed Apr 16, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-158079. Last ingested by Listed: Nov 4, 2026, 17:31 ET. No prices; not investment advice.